Skip to main content
// //

What are we looking for?

Solid, growth-oriented health-care companies.

The screen

So it finally happened. Cannabis is now legal for recreational use in Canada. And while we have seen great momentum stocks with lots of trading volume, investments in cannabis producers have been wrought with volatility, and have arguably lacked reasonable valuations and growth fundamentals from the perspective of a disciplined investor. Certainly a great ride, but likely not for everyone. For the significantly more traditional growth-oriented investor, I turn your attention to the broader health-care sector in the United States (today consisting of 250 companies in the CPMS U.S. database) to look for sound companies that have shown a reasonable history of growth. I find these companies by ranking the universe on:

  • Five-year sales and earnings-per-share growth (on average, how much the top line and bottom line have grown each year in the past five years);
  • Five-year average return on equity;
  • Five-year variability of earnings (a statistical measure showing how consistent a company’s earnings have been over the past five years, lower figures preferred);
  • Three-month estimate revision (today’s consensus estimate compared against the same figure three months ago);
  • Quarterly earnings momentum (latest four quarters of earnings compared against the same figure one quarter ago).

To qualify, companies must have a market capitalization greater than US$1.2-billion (this figure removes the bottom one-third of stocks from our universe of 250 by size, to ensure reasonable liquidity).

Story continues below advertisement

More about Morningstar

Morningstar Research Inc. provides independent investment research in North America, Europe, Australia and Asia. Its research tool, Morningstar CPMS, provides quantitative North American equity research and portfolio analysis to institutional clients and financial advisers. CPMS data cover more than 95 per cent of the investable North American stock market.With more than 110 equity and credit analysts, Morningstar has one of the largest independent institutional equity research teams in the world.

What we found

I used Morningstar CPMS to back-test this strategy from April, 2004, to September, 2018. During this process, a maximum of 10 stocks were purchased and equally weighted with no more than two for each sub-industry within the health-care sector. Once a month, stocks were sold if their rank fell below the top 35 per cent of the ranked universe, if consensus estimates dropped by more than 10 per cent or if the stock missed earnings expectations by more than 5 per cent. When sold, the positions were replaced with the highest-ranked stock not already owned in the portfolio. Over this period, the strategy produced an annualized total return of 14.5 per cent while the S&P 500 Health Care Total Return Index gained 10.2 per cent. The stocks that qualify for purchase today (none of which pay a dividend) are listed in the accompanying table.

It is always recommended to speak to a financial adviser or investment professional before investing.

Select U.S.-listed health-care companies

Rank Company Ticker Healthcare Sub-Industry Market Cap (US$Mil) 5Y EPS Growth (%/Y) 5Y EPS Variability 5Y Avg. ROE (%) 5Y Sales Growth (%/Y) Qtrly Earns Momentum (%) 3M EPS Estim. Revisions (%) Latest Earns Surprise (%) Recent Price (US$/Share)
1 Molina Healthcare Inc. MOH-N Managed Health Care 8,868.4 50.7 32.7 9.4 23.3 61.1 34.8 34.2 143.59
2 ICU Medical Inc. ICUI-Q Health Care Supplies 5,614.8 29.1 21.3 9.0 44.1 35.5 6.1 18.9 274.33
3 ABIOMED Inc. ABMD-Q Health Care Equipment 17,362.1 84.0 25.0 12.0 36.3 13.8 0.7 0.4 386.88
4 BioTelemetry Inc. BEAT-Q Health Care Services 1,852.8 58.2 18.8 13.0 14.2 25.3 6.3 16.1 56.62
5 Regeneron Pharma Inc. REGN-Q Biotechnology 43,062.6 50.3 20.9 22.2 29.2 7.9 3.1 1.7 398.52
6 Celgene Corp. CELG-Q Biotechnology 59,279.4 30.4 8.3 56.3 23.0 3.0 0.9 1.4 84.28
7 Athenahealth Inc. ATHN-Q Health Care Technology 5,069.2 64.7 53.3 6.3 17.2 24.7 6.4 24.5 125.16
8 Medidata Solutions Inc. MDSO-Q Health Care Technology 4,251.3 45.8 20.7 8.9 15.4 6.4 0.0 2.0 69.61
9 Illumina Inc. ILMN-Q Life Sciences Tools & Services 48,007.3 22.6 13.6 23.0 15.6 12.8 6.4 10.0 326.58
10 Mettler-Toledo International Inc. MTD-N Life Sciences Tools & Services 14,462.4 14.2 3.9 62.2 7.3 4.1 -0.4 0.5 573.59

Source: Morningstar Canada

Ian Tam, CFA, is a relationship manager for CPMS at Morningstar Research Inc.

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies